Relmada Therapeutics, Inc. (RLMD) vs Turn Therapeutics Inc. (TTRX)
A side-by-side comparison of Relmada Therapeutics, Inc. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RLMD
Relmada Therapeutics, Inc.
$3.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TTRX
Turn Therapeutics Inc.
$11.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RLMD vs TTRX
growth of $100 · dividends reinvested · last 1yRLMD +67.3% (+67.3%/yr)TTRX +76.6% (+76.6%/yr)TTRX compounded faster over this window
RLMD TTRX
RLMD vs TTRX: by the numbers
- •TTRX is the larger company ($347M vs $344M market cap).
Metrics side by side
Valuation
| Metric | RLMD | TTRX |
|---|---|---|
| P/B ratio | 1.67 | 504.79 |
Profitability
| Metric | RLMD | TTRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -29.98% | -1229.58% |
| ROIC | -30.78% | -84.66% |
Growth (annualized)
| Metric | RLMD | TTRX |
|---|---|---|
| Total return CAGR (5Y) | -7.68% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.